Abdominal obesity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria of abdominal obesity patients ( 1 ) People who met the above diagnostic criteria and were diagnosed with abdominal obesity ; ( 2 ) Gender unlimited age 18-55 years old ( 3 ) Those who signed informed consent and voluntarily accepted the intervention method of this project. Note : Patients who meet the above three items at the same time can be included in this study. Inclusion criteria for healthy subjects : ( 1 ) Waist circumference in the normal range of the population that is male waist circumference < 90cm female waist circumference < 85cm ; ( 2 ) without heart liver kidney digestive tract respiratory blood nervous system and other diseases ; ( 3 ) Physical examination found no positive signs of clinical significance ; ( 4 ) regardless of gender aged 18-55 years old ; ( 5 ) The health examination items were normal ; ( 6 ) To sign informed consent and voluntarily accept the research method of this project. Note : People who meet the above 6 items at the same time can be included in this study.
Exclusion criteria
Exclusion criteria: Exclusion criteria for patients with abdominal obesity ( 1 ) exclusion of infectious diseases including a clear focus of infection or systemic infectious diseases ; ( 2 ) Exclude pregnant perinatal lactating menopausal women and women who plan to be pregnant within 24 weeks ; ( 3 ) Obesity caused by hypothyroidism hypothalamic pituitary disease Cushing 's syndrome polycystic ovary syndrome and other diseases ; ( 4 ) Malignant tumors cirrhosis and other serious primary diseases coronary heart disease stroke and other secondary cardiovascular and cerebrovascular events and patients with mental illness. ( 5 ) Have a history of clinical diagnosis of eating disorders such as bulimia excessive appetite anorexia etc. in the past three months weight fluctuations greater than 5Kg ; ( 6 ) In the past 3 months they have taken drugs known to affect weight or appetite such as weight loss drugs corticosteroids antidepressants diazepams non-selective systemic antihistamines nicotine substitutes hypoglycemic drugs etc. ; those who have plans to quit smoking or drinking ; ( 7 ) Those who have a history of surgical weight loss or have participated in clinical research on weight loss in the past six months or are taking drugs diet or exercise interventions to lose weight ; ( 8 ) Treatment of local skin ulceration metal Chinese medicine preparation allergy and suffering from other serious skin diseases ; ( 9 ) those who could not cooperate and persist during treatment and follow-up. Exclusion criteria for healthy subjects ( 1 ) pregnant lactating menopausal women or women with pregnancy plan within half a year ; ( 2 ) those who took the known drugs that had an impact on this study in the past six months ; ( 3 ) Participated in other clinical researchers in the past six months ; ( 4 ) Patients with primary diseases in important organs ; ( 5 ) patients with mental or physical disabilities ; ( 6 ) unable to cooperate with and adhere to the researcher.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Waist circumference; | — |
Secondary
| Measure | Time frame |
|---|---|
| Waist-hip ratio;Body weight;TCM Constitution Scale;Non-target metabolomics assays;Liver Elastography;Body mass index;Blood uric acid;Subcutaneous fat ;Total cholesterol;TCM syndrome scale;Hip circumference;High density lipoprotein cholesterol;Triglycerides;Low-density lipoprotein cholesterol;Maximum preperitoneal fat thickness;Abdominal wall fat index;Fasting C peptide;Fasting blood glucose;Percentage of body fat;Intra-abdominal fat thickness;Fasting insulin;Waist-height ratio; | — |
Countries
China
Contacts
Dongfang Hospital Beijing University of Chinese Medicine